597 related articles for article (PubMed ID: 36341878)
1. Genotoxicity assessment of per- and polyfluoroalkyl substances mixtures in human liver cells (HepG2).
Ojo AF; Peng C; Ng JC
Toxicology; 2022 Dec; 482():153359. PubMed ID: 36341878
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the individual and combined toxicity of perfluoroalkyl substances to human liver cells using biomarkers of oxidative stress.
Ojo AF; Xia Q; Peng C; Ng JC
Chemosphere; 2021 Oct; 281():130808. PubMed ID: 34022600
[TBL] [Abstract][Full Text] [Related]
3. Combined effects and toxicological interactions of perfluoroalkyl and polyfluoroalkyl substances mixtures in human liver cells (HepG2).
Ojo AF; Peng C; Ng JC
Environ Pollut; 2020 Aug; 263(Pt B):114182. PubMed ID: 32247900
[TBL] [Abstract][Full Text] [Related]
4. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
[TBL] [Abstract][Full Text] [Related]
5. Toxicological Response of Chironomus dilutus in Single-Chemical and Binary Mixture Exposure Experiments with 6 Perfluoralkyl Substances.
McCarthy CJ; Roark SA; Wright D; O'Neal K; Muckey B; Stanaway M; Rewerts JN; Field JA; Anderson TA; Salice CJ
Environ Toxicol Chem; 2021 Aug; 40(8):2319-2333. PubMed ID: 33835531
[TBL] [Abstract][Full Text] [Related]
6. The impact of legacy and novel perfluoroalkyl substances on human cytochrome P450: An in vitro study on the inhibitory potential and underlying mechanisms.
Amstutz VH; Cengo A; Sijm DTHM; Vrolijk MF
Toxicology; 2022 Feb; 468():153116. PubMed ID: 35121066
[TBL] [Abstract][Full Text] [Related]
7. Perfluoroalkylated substances (PFAS) affect oxidative stress biomarkers in vitro.
Wielsøe M; Long M; Ghisari M; Bonefeld-Jørgensen EC
Chemosphere; 2015 Jun; 129():239-45. PubMed ID: 25455676
[TBL] [Abstract][Full Text] [Related]
8. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
[TBL] [Abstract][Full Text] [Related]
9. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of perfluoroalkyl substances (PFAS) and body composition - A cross-sectional study in a middle-aged population.
Lind PM; Lind L; Salihovic S; Ahlström H; Michaelsson K; Kullberg J; Strand R
Environ Res; 2022 Jun; 209():112677. PubMed ID: 35074350
[TBL] [Abstract][Full Text] [Related]
11. Perfluoroalkyl acids in pregnant women from Nunavik (Quebec, Canada): Trends in exposure and associations with country foods consumption.
Caron-Beaudoin É; Ayotte P; Blanchette C; Muckle G; Avard E; Ricard S; Lemire M
Environ Int; 2020 Dec; 145():106169. PubMed ID: 33041046
[TBL] [Abstract][Full Text] [Related]
12. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
[TBL] [Abstract][Full Text] [Related]
13. Antibody response to COVID-19 vaccines among workers with a wide range of exposure to per- and polyfluoroalkyl substances.
Porter AK; Kleinschmidt SE; Andres KL; Reusch CN; Krisko RM; Taiwo OA; Olsen GW; Longnecker MP
Environ Int; 2022 Nov; 169():107537. PubMed ID: 36183490
[TBL] [Abstract][Full Text] [Related]
14. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
[TBL] [Abstract][Full Text] [Related]
15. Association between perfluoroalkyl substances concentration and bone mineral density in the US adolescents aged 12-19 years in NHANES 2005-2010.
Xiong X; Chen B; Wang Z; Ma L; Li S; Gao Y
Front Endocrinol (Lausanne); 2022; 13():980608. PubMed ID: 36277702
[TBL] [Abstract][Full Text] [Related]
16. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
[TBL] [Abstract][Full Text] [Related]
17. Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019.
Göckener B; Weber T; Rüdel H; Bücking M; Kolossa-Gehring M
Environ Int; 2020 Dec; 145():106123. PubMed ID: 32949877
[TBL] [Abstract][Full Text] [Related]
18. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies.
Mamsen LS; Björvang RD; Mucs D; Vinnars MT; Papadogiannakis N; Lindh CH; Andersen CY; Damdimopoulou P
Environ Int; 2019 Mar; 124():482-492. PubMed ID: 30684806
[TBL] [Abstract][Full Text] [Related]
19. Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women's Health Across the Nation (SWAN).
Park SK; Wang X; Ding N; Karvonen-Gutierrez CA; Calafat AM; Herman WH; Mukherjee B; Harlow SD
Diabetologia; 2022 Jul; 65(7):1157-1168. PubMed ID: 35399113
[TBL] [Abstract][Full Text] [Related]
20. Investigating the cytotoxicity of per- and polyfluoroalkyl substances in HepG2 cells: A structure-activity relationship approach.
Amstutz VH; Cengo A; Gehres F; Sijm DTHM; Vrolijk MF
Toxicology; 2022 Oct; 480():153312. PubMed ID: 36075290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
